Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 2
1971 2
1973 3
1974 8
1975 9
1976 9
1977 7
1978 9
1979 10
1980 8
1981 8
1982 6
1983 11
1984 17
1985 17
1986 33
1987 19
1988 17
1989 19
1990 19
1991 19
1992 18
1993 14
1994 10
1995 19
1996 13
1997 20
1998 15
1999 9
2000 19
2001 22
2002 22
2003 35
2004 21
2005 21
2006 30
2007 27
2008 28
2009 33
2010 22
2011 31
2012 35
2013 58
2014 53
2015 60
2016 52
2017 84
2018 100
2019 37
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,059 results
Results by year
Filters applied: . Clear all
Page 1
Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle.
Kim R. Cancer Metastasis Rev 2017 - Review. PMID 27866303
This review discusses data from the available literature on anesthetic techniques applied in oncologic surgery, the long-term outcomes of anesthetic technique, and their relation to survival and cancer recurrence. Searches of the PubMed database up to June 30, 2016, were conducted to identify publications with the terms "anesthetic technique and cancer recurrence," "regional anesthesia and cancer recurrence," "local anesthesia and cancer recurrence," "anesthetic technique and immunosuppression," and "anesthetic technique and oncologic surgery." ...
This review discusses data from the available literature on anesthetic techniques applied in oncologic surgery, the long-term outcomes of an …
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
Krall JA, et al. Sci Transl Med 2018. PMID 29643230 Free PMC article.
Patients undergoing surgical resection of primary breast tumors confront a risk for metastatic recurrence that peaks sharply 12 to 18 months after surgery. ...Furthermore, we demonstrate that perioperative anti-inflammatory treatment markedly reduces tumor outgrowth in this model, suggesting that similar approaches might substantially reduce early metastatic recurrence in breast cancer patients....
Patients undergoing surgical resection of primary breast tumors confront a risk for metastatic recurrence that peaks sharply 12 to 18 …
Immunotherapy as a Potential Treatment for Chordoma: a Review
Patel SS and Schwab JH. Curr Oncol Rep 2016 - Review. PMID 27475804
The gold standard for treatment is en bloc resection, with some centers now advocating for the use of radiation to help mitigate the risk of recurrence. Local recurrence is common, and salvaging local failures is quite difficult. Chemotherapy has been ineffective and small molecule targeted therapy has had only marginal benefits in small subsets of patients with rare tumor phenotypes or refractory disease. ...
The gold standard for treatment is en bloc resection, with some centers now advocating for the use of radiation to help mitigate the risk of …
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.
Heindl A, et al. J Natl Cancer Inst 2018. PMID 28859291 Free PMC article.
The prognostic significance of immune scores was compared with Oncotype DX 21-gene recurrence score (RS), PAM50 risk of recurrence (ROR) score, IHC4, and clinical treatment score, available for 963 patients. ...The prognostic value of spatial scores for late recurrence was similar to that of IHC4 and RS in both populations, but was not as strong as other tests in comparison for recurrence across 10 years. ...
The prognostic significance of immune scores was compared with Oncotype DX 21-gene recurrence score (RS), PAM50 risk of recurrence
Relationship between Volatile Anesthetics and Tumor Progression: Unveiling the Mystery
Jiao B, et al. Curr Med Sci 2018 - Review. PMID 30536056
In this article, we review the association of diverse volatile anesthetic agents with immune system and cancer cell biology, and examine the effects on angeogenesis and postoperative metastasis or recurrence. ...
In this article, we review the association of diverse volatile anesthetic agents with immune system and cancer cell biology, and examine the …
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance
Althobiti M, et al. Histopathology 2018. PMID 29947077
A subset of full-face haematoxylin and eosin (H&E)-stained slides were examined for TILs heterogeneity within primary tumours and the corresponding local recurrent carcinomas to investigate spatial and temporal TILs heterogeneity. ...High AV-TILs in recurrent tumours showed a significant association with shorter post-recurrence survival (P = 0.004). CONCLUSIONS: Despite the heterogeneity of immune cell type components, average TILs in one full-face H&E-stained section reliably represent TILs in the whole tumour. ...
A subset of full-face haematoxylin and eosin (H&E)-stained slides were examined for TILs heterogeneity within primary tumours and the co …
Impact of Regional Anesthesia on Recurrence, Metastasis, and Immune Response in Breast Cancer Surgery: A Systematic Review of the Literature.
Pérez-González O, et al. Reg Anesth Pain Med 2017 - Review. PMID 28953508
The selected studies were divided into 3 groups to determine the impact of PVB on (a) recurrence and survival, (b) humoral response, and (c) cellular immune response. ...CONCLUSIONS: Our study indicates that there are no data to support or refute the use of PVB for reduction of cancer recurrence or improvement in cancer-related survival. ...
The selected studies were divided into 3 groups to determine the impact of PVB on (a) recurrence and survival, (b) humoral response, …
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
Shelton E, et al. Gastroenterology 2016 - Review. PMID 27039969 Free PMC article.
METHODS: We searched Medline, EMBASE, and conference proceedings for terms related to immune-mediated disease, immune-suppressive therapy, and cancer recurrence from inception to April 2015. ...CONCLUSIONS: In a meta-analysis of 16 studies, we observed similar rates of cancer recurrence among individuals with prior cancer who received no immunosuppression, anti-TNF therapy, immune-modulator therapy, or combination treatments. ...
METHODS: We searched Medline, EMBASE, and conference proceedings for terms related to immune-mediated disease, immune-suppressive therapy, a …
1,059 results
Jump to page
Feedback